According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$26.84 Million. In 2024 the company made an earning of -A$55.95 Million a decrease over its 2023 earnings that were of -A$38.76 Million. The earnings displayed on this page is the company's Pretax Income.